September 14, 2017 — Here are quick summaries for all the key late-breaking vascular and endovascular clinical trials presented at VIVA 2017 this week.
Stents Peripheral
Peripheral stents are used to open narrow and hardening arteries that supply blood to the legs and feet.
-
-
LimFlow SA announced in November that it received the CE Mark for its fully percutaneous LimFlow System designed for venous arterialization of the lower limbs in end-stage patients at risk of limb...
-
-
August 2, 2016 —The U.S. Food and Drug Administration (FDA) granted market clearance for W. L.
News | Peripheral Artery Disease (PAD) | May 15, 2018
May 15, 2018 — The Society for Cardiovascular Angiography and Interventions (SCAI) has released new guidelines to...
News | Stents Peripheral | April 27, 2018
April 27, 2018 — Intact Vascular Inc. recently closed a Series C financing totaling $20 million. This financing is...
News | Cardiovascular Clinical Studies | February 01, 2018
February 1, 2018 – Thomas Zeller (Bad Krozingen, Germany) presented the 12-month results from Veryan Medical’s...
Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.
Feature | Cath Lab | September 14, 2017
September 14, 2017 — Here are quick summaries for all the key late-breaking vascular and endovascular clinical...
News | Stents Peripheral | July 26, 2017
July 26, 2017 — Intact Vascular Inc. recently announced that its Tack Optimized Balloon Angioplasty II Below the...
News | Peripheral Artery Disease (PAD) | July 17, 2017
July 17, 2017 — LimFlow SA announced enrollment of the first patient in the U.S....
News | Stents Peripheral | July 14, 2017
July 14, 2017 — Intact Vascular Inc. announced the U.S. Food and Drug Administration (FDA) approved an...
News | Stents Peripheral | April 28, 2017
April 28, 2017 — Biotronik’s Pulsar-18 bare metal stent (BMS) has yielded high primary patency in a real-world...
News | Stents Peripheral | March 16, 2017
March 16, 2017 — W. L. Gore & Associates Inc. recently announced the Health Canada approval of the Gore Tigris...
News | Stents Peripheral | March 02, 2017
March 2, 2017 — Intact Vascular Inc. announced in February that its Tack Optimized Balloon Angioplasty II Below the...
News | Stents Peripheral | December 13, 2016
December 13, 2016 — Biotronik announced the presentation of data confirming the efficacy of the Pulsar-18...
News | Stents Peripheral | December 08, 2016
December 8, 2016 — LimFlow SA announced in November that it received the CE Mark for its fully percutaneous LimFlow...
Feature | Cath Lab | September 28, 2016
September 28, 2016 — The Cardiovascular Research Foundation (CRF) included 11 late-breaking trials and 16 first...
The FDA clearance of the first bioresorbable stent, the Abbott Absorb, the first week of July has been the most popular story so far for all of 2016. It is the first fully dissolving stent approved for the U.S. market and many experts say this technology could be a paradigm shift in coronary and peripheral therapies in the coming years as the technology improves.
Feature | August 05, 2016 | Dave Fornell
August 5, 2016 — Here are the top 20 most popular current content on the Diagnostic and Interventional...
The Gore Tigris is a dual-component stent with a unique fluoropolymer / nitinol design.
Technology | Stents Peripheral | August 02, 2016
August 2, 2016 —The U.S. Food and Drug Administration (FDA) granted market clearance for W. L. Gore & Associates...
